What's on the label is the measured result — net peptide mass, not gross powder weight, plus RP-HPLC purity, on a lot-numbered COA for every batch.
Net peptide mass and RP-HPLC purity — a lot-numbered COA for every batch.
Net peptide mass + HPLC purity, per lot.
PCAC will review 7 peptides for the 503A bulks list, BPC-157, KPV, TB-500, MOTS-c, Emideltide, Semax, Epitalon. Read our briefing →
PCAC will review 7 peptides for the 503A bulks list. Read →
FDA PCAC reviews 7 peptides in July. Read →
Reference-code fill; Tirzepatide identity verified per batch COA · 10 mg
Overview
GLP1-T-10 is a reference code within the Tirzepatide-class branch of the metabolic-GLP-1 catalog, with the 'T' designator indicating Tirzepatide GIP/GLP-1 dual agonist material and the '10mg' fill quantity per vial. The 10 mg fill is the smallest in the T-series fills (alongside the 30 mg and 60 mg variants), more appropriate for pilot-scale research or for distributor buyers requiring smaller dispensing presentations. As with all reference-code SKUs, API identity, sequence, and CAS is verified against the released batch-specific COA at order time; the named Tirzepatide SKU is the cleaner procurement route for direct end-buyers.
Who buys this, and why
Most buyers in this category are 503A and 503B compounding pharmacies fulfilling metabolic and weight-management protocols, plus research labs investigating GLP-1 / GIP / GCG receptor pharmacology. The procurement decision usually hinges on three things: documented purity at scale, a regulatory team that can respond on destination-market questions in writing, and the ability to supply consistent counter-ion form (acetate by default) across recurring orders.
Primary buyer fit: regional distributors and re-sellers.
Specifications
Documentation available on request
Regulatory note
Reference code; verify API identity via batch-specific COA before order placement.
Frequently asked questions
The T-series fills (10, 30, 60 mg) target different downstream workflows. The 10 mg fill is the smallest in the series and matches pilot-scale research or distributor pre-fractionation workflows where the full T-60 would be excessive. The 30 mg fill is the most-commonly-ordered size for typical distributor workflows because it balances per-vial cost economics against the dispensing-fill sizes preferred by downstream compounding pharmacy buyers. The 60 mg fill is for bulk distributors needing larger per-vial quantities. For direct end-buyers, the named Tirzepatide SKU offers 12 fill sizes from 2 mg to 120 mg, substantially more flexibility than the reference-code path.
Compounding pharmacy dispensing of Tirzepatide-class material typically uses standard mg-equivalent doses (5 mg, 10 mg, 15 mg, 20 mg, 25 mg total dose) prepared from the bulk vial. The GLP1-T-10 fill at 10 mg total is therefore directly usable as a single 10-mg-dose preparation, or fractionated into two 5-mg-dose preparations. For pharmacies running larger workflows that prefer single-dose dispensing across all common sizes, the named Tirzepatide SKU (with its 12 fill sizes) is more operationally efficient because it eliminates the in-house fractionation step. The GLP1-T-10 path is more economical at small distributor volumes but adds fractionation overhead at larger volumes.
Counterfeiting and identity-substitution are real concerns in the global Tirzepatide and Semaglutide supply chains, where the high commercial value of the named molecules has attracted unauthorized substitution with cheaper alternatives (Liraglutide, partial sequences, or in extreme cases, non-GLP-1 peptides). The reference-code path is potentially more vulnerable than the named-API path because the catalog-level identity is opaque. PeptideXpo's compliance check on reference-code SKUs includes mass-spec verification against the claimed API at batch receipt, buyers should always request the verified-identity statement on the COA and consider in-house mass-spec or sequence-verification testing for any first-time order from a new reference-code source.
Related peptides
GIP / GLP-1 dual receptor agonist
Reference-code fill; Tirzepatide identity verified per batch COA · 30 mg
Reference-code fill; Tirzepatide identity verified per batch COA · 60 mg
